HIV/AIDS and the use of mathematical models in the theoretical assessment of intervention strategies: A review

Advances in Disease Epidemiology

Volumn , Issue , 2009, Pages 221-241

  Mukandavire, Zindoga ^a   Tchuenche, Jean M ^b   Chiyaka, Christinah ^a   Musuka, Godfrey ^c  

^a NATIONAL UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Zimbabwe)

^b UNIVERSITY OF DAR ES SALAAM   (Tanzania)

^c African Comprehensive HIV/AIDS Partnerships   (Botswana)

Author keywords

Hiv aids; Intervention strategies; Mathematical modelling; Theoretical assessment

Indexed keywords

EID: 77955974771     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (101)

1. Anderson R.M.,May R.M. andMaclean A. R., Possible demographic consequences of AIDS in developing countries, Nature, 332, 228-234, 1988.
2. Anderson R. M., Gupta S. and May R. M., Potential of community wide chemotherapy or immunotherapy to control the spread of HIV-1, Nature, 350, 356-359, 1991.
3. Anderson R. M. and May R. M., Infectious diseases of humans, Oxford University Press Oxford, 1991.
4. Anderson R. M. and Hanson M., Potential public health impact of imperfect HIV type 1 vaccines. J Infect. Dis., 191(1), 85-96, 2005.
5. Andersson H. and Britton T., Stochastic EpidemicModels and Their Statistical Analysis, Lect. Notes in Stat., Springer-Verlag, 151, 2000.
6. Auvert B., Taljaaard D., Lagarde E., Sobngwi-Tambekou J., et al., Randomized controlled intervention trial of male circumcision for reduction of HIV infection risk, PLOS medicine, 1, 1-32, 2005.
7. Baggaley R. F., Ferguson N. M. and Garnett G. P., The epidemiological impact of antiretroviral use predicted by mathematical models: a review, Emerg. Themes Epidemiol., 2005 (http://www.biomedcentral.com/1742-7622/2/9, retrieved August 14, 2008).
8. Bailey N. T. J, The mathematical theory of infectious diseases and its applications, second edition, Oxford University Press, New York, 1975.
9. Blower S. M. and Maclean A. R., Prophylactic vaccines, risk behaviour change, and the probability of eradication in San Francisco, Science, 265, 1451-1454, 1994.
10. Blower S. M., Gershengorn H. B. and Grant R. M., A tale of two futures: HIV and antiretroviral therapy in San Francisco, Science, 287, 650-654, 2000.
11. Blower S. M., Aschenbach A. N., Gershengorn H. B. and Kahn J. O., Predicting the unpredictable: transmission of drug resistant HIV, Nat. Med., 7, 1016, 2001.
12. Blower S.M., Koelle K. andMills J., Health policy modeling: epidemic control, HIV vaccines and risky behavior, in Quantitative Evaluation of HIV Prevention Programs. Eds Kaplan and Brookmeyer, Yale University Press, 260-289, 2002.
13. Blower S.M.,Moss R.B. and Fernandez-Cruz E., Calculating the potential epidemiclevel impact of therapeutic vaccination on the San Francisco HIV epidemic, AIDScience, 3, 21, 2003.
14. Blower S. M., Bodine E. N. and Grovit-Ferbas K, Predicting the potential public health impact of disease-modifying HIV vaccines in South Africa: The problem subtype, Current drug targets-Infectious disorders, Bentham Science Publishers Ltd, 2005.
15. Bongaarts J., Reining P., Way P. and Conant F., The relationship between male circumcision and HIV infection in African populations. Aids, 3, 373-377, 1989.
16. Busenberg S., Cooke K. and Hsieh Y.-H., A model for HIV in Asia, Math. Biosci. 128, 185-210, 1995
17. Caldwell J. C. and Caldwell P., The African AIDS epidemic, Sci. Am. 274, 62-68, 1996.
18. Cameron D. W., Simonsen J. N., D'Costa L. J., et al., Female to male transmission of human immunodefi-ciency virus type 1: risk factors for seroconversion in men, Lancet, 2(8660), 403-407, 1989.
19. Castillo-Chavez C. and Busenberg S., On the solution of the two-sex mixing problem, in: Differential Equations Models in Biology, Epidemiology and Ecology, Proceedings, Claremont 1990 (ed. S. Busenberg and M. Martelli). Lect. Notes in Biomath. 92. New York: Springer-Verlag, 80-98, 1991.
20. Castillo-Chavez C., Busenberg S. and Gerow K., Pair formation in structured populations, in: Differential Equations with applications in Biology, Physics and Engineering (J. Goldstein, F. Kappel,W. Schappacher). Marcel Dekker, New York, 1991.
21. Cooke K. L. and Yorke J. A., Some equations modelling growth processes and gonorrhea epidemics, Math. Biosci., 16, 75-101, 1973.
22. Corbett E. L., Steketee R. W., ter Kuile F. O., Latif A. S., Kamali A., and Hayes R. J., AIDS In Africa III: HIV-1/AIDS and the control of other infectious diseases in Africa, Lancet, 359, 2177-87, 2002.
23. DavenportM. P., Ribeiro R.M., Chao D. L. and Perelson A. S., Predicting the Impact of a Nonsterilizing Vaccine against Human Immunodeficiency Virus, J. Virol., 78, 11340-11351, 2004.
24. Del Valle S., Evangelista A. M., Velasco M. C., Kribs-Zaleta C. M. and Hsu Schmitz S. F., Effects of education, vaccination and treatment on HIV transmission in homosexuals with genetic heterogeneity, Math. Biosci., 187, 111-133, 2004.
25. Diekmann O., Limiting behaviour in an epidemic model, Nonl. Anal., Theor., Meth. and Appl., 1(5), 459-470, 1977.
26. Dietz K. and Hadeler K. P., Epidemiological models for sexually transmitted diseases, J. Math. Biol., 26, 1-25, 1988.
27. Fink A., A possible explanation for heterosexual male infection with AIDS, N. Engl. J. Med., 314, 1167, 1986.
28. Gabriel J. P., Lefevre C. and Picard C., Stochastic Processes in Epidemic Theory, Lect. Notes in Biomath. 90, Springer Verlag, 1990.
29. Garnett G.P., Desai K. andWilliams J., The Epidemiological Impact of an HIV/AIDS Vaccine in Developing Countries. Technical Annex 1. The potential impact of prophylactic HIV vaccination as a function of vaccine properties: Results of the Imperial College Model. Technical appendix to Garnett, G.P., Forsythe, S.,Seitz, S., Stover, J. The Epidemiological Impact of and HIV/AIDS Vaccine inDeveloping Countries, World Bank. (March 2002), 2001.
30. Ghys P. D., Brown T., Grassly N. C., Garnett G., et al., The UNAIDS Estimation and Projection Package, a software package to estimate and project national HIV epidemics, Sex Transm. Infect., 5-9, 2004.
31. Gordon R. A critical review of the physics and statistics of condoms and their role in individual versus societal survival of the AIDS epidemic. J. Sex Marital Ther 15 (1), 5-30, 1989.
32. Grais R. F., Ellis J. H., Kress A. and Glass G.E., Modeling the spread of annual influenza epidemics in the U.S.: The potential role of air travel, Health Care Management Science, 7(2), 127-134, 2004.
33. Gray R.H., Xianbin L.,Wawer M.J., Gange S.J., Serwadda D., et al., Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda, AIDS, 17, 1941-1951, 2003.
34. Greenhalgh D., Doyle M. and Lewis F., A mathematical treatment of AIDS and condom use, IMA J. Math. App. Med. Biol., 18, 225-262, 2001.
35. Hadeler K. P., Pair formation in age-structured populations, Acta Applicandae Mathematicae, 3, 1-11, 1989.
36. Hadeler K. P., Waldsttter R. and Wrz A., Models for pair formation in two-sex populations, J. Math. Biol., 1988.
37. Harrington M., Huff B., Camp R., Jeffreys R., Swan T., et al., Whats in the pipeline? New HIV drugs, vaccines, microbicides, HCV and TB treatments in clinical trials, New York: Treatment Action Group, 2005.
38. Hethcote H. W. and Van Ark J. W., Modelling HIV transmission and AIDS in the United States, Lect. Notes in Biomath., Springer-Verlag, Berlin, Heidelberg, 1980.
39. Hoppensteadt F., An age dependent epidemic model, Journal of the Franklin Institute, 297, 325-333, 1974.
40. Hraba T and Dolezal J., Use of a Mathematical Model for Effectivity Estimation of HIV Infection Therapies, Appl. Math. Comput. 78, 153-161, 1996.
41. Hsieh Y.-H., Modelling the effects of screening in HIV transmission dynamics, Differential Equations Models in Biology Epidemiology (Lect. Notes in Biomath. 92), S. Busenberg and M. Martelli, eds., Springer-Verlag, Berlin 99-120, 1991.
42. Hsieh Y.-H. and Velasco-Herńandez J. X., Community treatment of HIV-1: Initial stage and asymptotic dynamics, Biosystems, 35, 75-81, 1995.
43. Hyman, J.M. and Li, J., Behavior changes in SIS STD models with selective mixing, SIAM J. App. Math., 57(4), 1082-1094, 1997.
44. Hyman J. M. and Stanley E. A., Using mathematical models to understand the AIDS epidemic, Math. Biosci, 90, 415-473, 1998.
45. Inaba H., Revisiting Kermack and McKendrick, 2000 (www.ms.utokyo. ac.jp/inaba/inaba2000RIMS.pdf, retrieved August 20, 2008).
46. Karmon E., Potts M. and GetzW. M., Microbicides and HIV: Help or Hindrance?, J. Acquir. Immune Defic. Syndr., 34, 71-75, 2003.
47. Kermack W. O. and McKendrick A. G., Contributions to the mathematical theory of epidemics-I, Proceedings of the Royal Society 115A: 700-721. (reprint in Bull. Math. Biol. 53(1/2), 33-55, 1991), 1927.
48. Kermack W. O. and McKendrick A. G., Contributions to the mathematical theory of epidemics-II. The problem of endemicity, Proceedings of the Royal Society 138A: 55-83. (reprint in Bull. Math. Biol. 53(1/2), 57-87, 1991), 1932.
49. Kermack W. O. and McKendrick A. G., Contributions to the mathematical theory of epidemics-III. Further studies of the problem of endemicity, Proceedings of the Royal Society 141A: 94-122. (reprint in Bull. Math. Biol., 53(1/2), 89-118, 1991), 1933.
50. Kribs-Zaleta C. M. and Velasco-Herńandez J. X., A simple vaccination model with multiple endemic states, Math. Biosci., 164, 183-201, 2000.
51. Law M. G., Prestage G., Grulich A., Van de Ven P. and Kippax S., Modelling the effect of combination antiretroviral treatments on HIV incidence, AIDS, 15(10), 1287- 1294, 2001.
52. Law M. G., Prestage G., Grulich A., Van de Ven P. and Kippax S., Modelling HIV incidence in gay men: increased treatment, unsafe sex and sexually transmissible infections, AIDS, 16(3), 499-501, 2002.
53. Leport F. and Blower S. M., The supply and demand dynamics of sexual behaviour implications for heterosexual HIV epidemics, J. AIDS., 4, 987-999, 1991.
54. Lin X., Hethcote H. W. and van den Driessche P., An epidemiological model for HIV/AIDS with proportionate recruitment, Math. Biosci., 118, 181-195, 1993.
55. McKendrick A. G., Applications of mathematics to medical problems, Proc. Edin. Math. Soc., 14, 98-130, 1926.
56. May R. M., Anderson R. M. and Mclean A. R., Possible demographic consequences of HIV/AIDS epidemics: Assuming HIV infection always leads to AIDS, Math. Biosci., 90, 475-505, 1988.
57. Mclean A. R. and Blower S.M., Imperfect vaccines and herd immunity to HIV, Proc. Roy. Soc. Lond., 253, 9-13, 1993.
58. Mclean A. and Blower S., Modelling vaccination, Trends in Microbiology, 3, 458- 463, 1995.
59. McNeill E. T., Gilmore C. E., Finger W. R., Lewis J. H. and Schellstede W. P., The Latex Condom: Recent Advances, Future Directions, Durham, North Carolina: FHI, 2001 (www.fhi.org/en/fp/fpother/conom/index.html, retrieved September 25, 2008).
60. Metz, J. A. J., The epidemic in a closed population with all susceptibles equally vulnerable; some results for large susceptible populations and small initial infections, Acta Biotheoretica 27, 1/2: 75-123, 1978.
61. Metz J. A. J. and Diekmann O. (eds.), The Dynamics of Physiologically Structured Populations, Lect. Notes in Biomath. 68, Springer, Berlin, 1986.
62. Moghadas S. M., Gumel A. B., McLeod R. G. and Gordon R., Could Condoms Stop the AIDS epidemic, J. Theor. Med., 5, 171-181, 2003.
63. Moses S., Bradley J. E., Nagelkerke N. J., Ronald A. R., Ndinya-Achola J. O., et al., Geographical patterns of male circumcision practices in Africa: Association with HIV seroprevalence, Int. J. Epidemiol. 19, 693-697, 1990.
64. Mukandavire Z. and W. Garira, Sex-structured HIV/AIDS model to analyse the effects of condomuse with application to Zimbabwe, Journal ofMathematical Biology, 54(5), 669-699, 2007.
65. Mukandavire Z., K. Bowa and W. Garira, Modelling circumcision and condom use as HIV/AIDS preventive control strategies, Mathematical and Computational Modelling, 46(11),1353-1372, 2007.
66. Mukandavire Z. and W. Garira, Effects of public health educational campaigns and the role of sexworkers on the spread of HIV/AIDS among heterosexuals, Theor. Popul. Biol., 72, 346-365, 2007.
67. Murray, J.D., Mathematical biology, Springer-Verlag Berlin Heidelberg New York, Ch. 19, 611-617, 1989.
68. Nagelkerke N. J. D. and De Vlas J. S., The epidemiological impact of an HIV Vaccine on the HIV/AIDS epidemic in Southern India, The World Bank Development Research Group, Public Services, 2003.
69. Modelling the spread of AIDS epidemic with vertical transmission, Appl. Math. Comput. 178, 262-272, 2006.
70. Potts M., Thinking about vaginal microbicides testing, Am. J. Public Health, 90, 188-190, 2000.
71. Ramjee G., Karim S. A., Morar N. S., et al., Acceptability of vaginal microbicides among female sex workers, S. Afr. Med. J., 89, 673-676, 1999.
72. Razan, M.R., Multiple endemic for an SIRS Epidemiological System (arXiv: math.CA/0101051 v1), 2001.
73. RHO, 2005 (http://www.AIDS/HIV-AIDS Special Focus-Condoms.htm, retrived September 28, 2008).
74. Rockefeller Foundation, The public health benefits of microbicides in lower-income countries model projections, 2001
75. Ross R., The Prevention of Malaria, John Murray, London, 1911.
76. Salomon J. A., Hogan D. R., Stover J., Stanecki K. A., Walker N., et al., Integrating HIV prevention and treatment: From slogans to Impact, PLOS Med., 2, 50-55, 2005.
77. Sangani P., Rutherford G. and Wilkinson D., Population-based interventions for reducing sexually transmitted infections, including HIV infection, Cochrane Database Syst. Rev. 2, CD001220, 2004.
78. Scalia-Tomba G., The effect of structural behaviour change on the spread of HIV in a one-sex population, Math. Biosci., 107, 547-555, 1991.
79. Seitz S., The Epidemiological Impact of an HIV/AIDS Vaccine in Developing Countries. Technical Annex 2. The Potential Epidemiological Impact of Prophylactic Vaccines: Results of the iwgAIDSModel. Technical appendix to Garnett, G.P., Forsythe, S., Seitz, S., Stover, J. The Epidemiological Impact of and HIV/AIDS Vaccine in Developing Countries, World Bank (March 2002), 2001.
80. Smith R.J. and Blower S.M., Could disease-modifying HIV vaccines cause population-level perversity?, Lancet Infect. Dis., 4, 636-639, 2004.
81. Soto-Ramirez L. E., Renjifo B., Mclane M. T., et al., HIV-1 Langerhans cell tropism associated with heterosexual transmission of HIV, Science, 71, 1291-3, 1996.
82. Stover J., Garnett G.P., Seitz S. and Forsythe S., The Epidemiological Impact of and HIV/AIDS Vaccine in Developing Countries, World Bank: Washington, DC, 2002.
83. Swinton J., A dictionary of epidemiology, 2003 (http://albany.net/tjc/gloss96.html, retrieved August 29, 2008).
84. Tallis V., Gender and HIV/AIDS overview report, BRIDGE development-gender, Institute of Development Studies, 2002.
85. Thieme H. R. and Castillo-Chavez C, How may infection-age-dependent infectivity affect the dynamics of HIV/AIDS?, SIAM J. App. Math., 53(5), 1447-1479, 1993.
86. Thomson J. R., AIDS: The mismanagement of an epidemic, Computers Math. Appl. 18(10/I 1), 965-972, 1989.
87. UNAIDS, HIV prevention needs and success, A tale of 3 countries, The stories of prevention successes in Senegal, Thailand and Uganda, 2001
88. UNAIDS, Report on the Global AIDS Epidemic, Geneva, 2004
89. UNAIDS, Report on the global AIDS epidemic, Geneva, 2006
90. UNAIDS/WHO, Report on the global HIV/AIDS epidemic, 1998
91. UNAIDS/WHO, AIDS epidemic update, Geneva, 2003
92. UNAIDS/WHO, AIDS epidemic update, Geneva, 2005
93. UNICEF Malaria Technical report No. 6, 2003.
94. Vernazza P. L., Gilliam B. L., Dyer J., Fiscus S. A., et al., Quantification of HIV in semen: correlation with antiviral treatment and immune status, AIDS, 987-993, 1997.
95. Velasco-Herńandez J. X., Gershengorn H. B. and Blower S. M., Could widespread use of combination antiretroviral therapy eradicate HIV epidemics, Lancet Infect. Dis., 2002 (http://infection.thelancet.com, retrieved August 29, 2008).
96. Velasco-Herńandez J. X. and Hsieh Y.-H., Modelling the effect of treatment and behavioral change in HIV transmission dynamics, J. Math. Biol., 32, 233-249, 1994.
97. Waldsttter R., Pair formation in sexually-transmitted diseases, Mathematical and Statistical Approaches to AIDS Epidemiology (Lect. Notes in Biomath., 83), Castillo-Chavez ed., Springer-Verlag, Berlin, 260-274, 1989.
98. Williams B. G., Lloyd-Smith J. O., Gouws E., Hankins C., GetzW. M., et al., (2006) The Potential Impact of Male Circumcision on HIV in Sub-Saharan Africa. PLoS Med 3(7): e262 doi:10.1371/journal.pmed.0030262
99. WHO, Prevention of mother-to-child transmission of HIV, Use of nevirapine among women of unknown serostatus, Report of a technical consultation, 2001
100. WHO, Scaling Up Antiretroviral Therapy in Resource Limited Settings: Guidelines for a Public Health Approach, WHO, 2002
101. WHO/UNAIDS. The Male Latex Condom, Condom Programming Fact Sheets, Geneva: WHO, 2001.